|
CURRICULUM VITAE AND BIBLIOGRAPY
Hamilton Health Sciences, Juravinski Cancer Centre, the Brain-Body Institute and
Departments of Oncology and Medicine, McMaster University, Hamilton, Ontario
Date of preparation: 04/07/09
A. GENERAL INFORMATION
1. Name: Stephen Mark Sagar, BSc (Hons), MB.BS, MRCP, FRCR, FRCP(C)
B. EDUCATIONAL BACKGROUND
1. Degrees
Degree Institution Dates Attended Year Awarded
BSc
Pharmacology Kings College 1975-78 1978
1st class honors. University of London
MB. BS
Pathology honors. St. George's Hospital 1978-81 1981
Medical School
University of London
C. PROFESSIONAL POSITIONS AND EMPLOYMENT
1. Post-doctoral training
Title Institution name/location Dates held
Internal medicine St. Georges/St. James Hospitals 1981-1985
Residency Ashford, Royal Marsden, Greenwich
Hospitals, London, UK
Clinical oncology Middlesex, Mount Vernon, Westminster 1985-1989
Residency Hospitals, London, UK
2. Academic positions
Title Institution name/location Dates held
Lecturer Radiology Memorial University, St. Johns, 1990-1991
Newfoundland, Canada
Assistant Professor Dalhousie University, Halifax, 1991-1993
Radiation Oncology Nova Scotia, Canada
Associate Professor McMaster University, Hamilton, 1993-present
Oncology and Medicine Ontario, Canada
3. Hospital Positions
Attending Staff Physician Newfoundland Cancer Treatment and 1990-1991
Research Foundation & St Johns General
Hospital, St Johns Nfld, Canada
Attending Staff Physician Cancer Treatment and Research 1991-1993
Foundation of Nova Scotia
and Queen Elizabeth II Hospital
Halifax, N.S., Canada
Attending Staff Physician Ontario Cancer treatment and Research 1993-present
Foundation, Hamilton Health Sciences
Corporation, Hamilton, Ont., Canada
4. Other Positions
Board Examiner (Radiation Oncology) for the Royal College of Physicians and Surgeons of Canada Ottawa, Canada; 1995-1999
Examiner for the Licentiate Examination of the Medical Council of Canada (LMCC); 1995, 1996
Examiner for the 1996 Advanced Certification in Radiation Therapy (ACT); 1995
Professional malpractice reviews for the College of Physicians and Surgeons of Ontario; 1998, 2008
D. LICENSURE, BOARD CERTIFICATION, MALPRACTICE
1. Licensure
a. Province Number Date of Issue Date of Last Registration
Ontario 66118 August 1993 May 2008
general
license
USMLE part 1 passed April 6, 2009
USMLE part 2 (CK) passed September 2009.
Canadian licensing exams: L.M.C.C.E.E. and L.M.C.C.Q.E. in 1991.
2a. Board Certification
Board Certificate Date
Royal College of Physicians (UK) MRCP (internal medicine) 1985
Royal College of Radiologists (UK) FRCR (clinical oncology) 1989
Royal College of Physicians & FRCPC (radiation oncology) 1992
Surgeons of Canada
American Board of Radiology Board Certified 1995
(radiation oncology)
Recertified: 38929 2005
2b. Other Certifications
3. Malpractice Insurance
CMPA: 0945641
E. PROFESSIONAL MEMBERSHIPS
ASTRO (1993-present) and ARS (1991-1994)
Member of ACR (1995-present)
President Society for Integrative Oncology 2009 (member: 2004-present)
F. HONORS AND AWARDS
European Community Fellowship Award, European School of Oncology, Lugano, Switzerland (1990)
Canadian Cancer Society Lerenbaum Scholarship for Studies in Mind-Body Medicine (1998)
Presidential Award of the American Association for Cancer Education: Paper on DVD Technology and Cancer Patient Education (2002)
Finalist in Dr. Rogers Prize for Excellence in Complementary Medicine in Canada (2007)
G. INSTITUTIONAL/HOSPITAL AFFILIATION
Primary Hospital: Juravinski Cancer Centre and Henderson Hospital, Hamilton Health Sciences Corporation
McMaster University, Departments of Oncology and Medicine
Brain Body Institute, St. Josephs Hospital, Hamilton
H. EMPLOYMENT STATUS
Hamilton Radiation Oncology Associates: Full time partnership private practice
I. CURRENT AND PAST INSTITUTIONAL RESPONSIBILITIES (since 2004)
Mutiple teaching sessions on integrative oncology for cancer patients in association with the Lymphoma Foundations of Canada and North America, Canadian Cancer Society, and the Wellspring Foundation
External Ph.D examiner for University of British Columbia: Rh2 and its glycone aPPD in combination therapy with docetaxel: preclinical evaluation in a human prostate xenograft model (2008)
Consultations, clinical management, and follow up of patients referred with head and neck cancers, lymphomas, and skin cancer (350 new patients per year)
Society for Integrative Oncology: Current President, member of executive, chair of clinical practice committee, and previous co-chair of the scientific program committee
Consortium of Academic Health Centers: McMaster co-representative; member of research committee and conference communication committee
1. A randomized trial of Codetron versus best supportive care to prevent radiation-induced xerostomia.
2. A pilot project to evaluate the effectiveness of a Japanese Herbal Medicine formula, Keishi-bukuryo-gan in alleviating hormonal ablation therapy induced vasomotor symptoms in prostate cancer patients.
4. Development of Natural Health Products for Cancer Patients: From Laboratory through Clinical Trials and Government Regulations.
Institute of Health Services and Policy Research (IHSPR) Research Community Development Funding Program (2006-2007); Amount: $7,000.
CV Technologies: $12,000
AIS (Alberta Innovation and Science) Fund: $2,500
Total Amount: $19,500
5. A phase I/II study to examine the accuracy of spinal cord functional MRI scan in evaluating chemotherapy induced peripheral neuropathy and the efficacy of acupuncture and acupuncture-like transcutaneous nerve stimulator in treating this condition.
P.I: R. Wong, M. Noseworthy, S. Sagar (30%)
6. An Open-Label Trial To Examine the Effects of a Proprietary Combination of Ginkgo Biloba and a Ginsenoside Derivative of Panax Quinquefolium (AD-fXTM)@ in Patients with Cognitive Impairment associated with a Primary Brain Tumour and its Treatment.
-
-
P.I: S. Sagar (80%); A. Whitton; W. Molloy T; Standish, MA; R. Wong
-
-
Amount: $50,000 per year for 4 years
-
-
8. Influence of therapeutic massage on the physiology of muscle and the central nervous system: evaluation by magnetic resonance spectroscopy and functional magnetic resonance imaging in healthy subjects and subjects with subacute low back pain.-2009)
-
-
P.I: R. Wong, T. Dryden, S. Sagar (20%)
9. RTOG Protocol 0537: A phase II/III study comparing acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) versus pilocarpine in treating early radiation-induced xerostomia
10. Natural health products in the prevention and treatment of lung cancer: a systematic and scoping review of the literature.
PI: Seely D, Collaborators: Seely AJE, Wong R, Sagar S (15%), Fergusson D.
12. Publication of Current Oncology supplement titled Integrative Medicine: A Canadian and International perspective
-
13. To create a sustainable centre dedicated to providing and researching integrative and preventative clinical cancer care.
Development of a web-based data collection tool to determine patients' psychosocial behavior and economic impact of complementary therapies and lifestyle. Canadian Cancer-CAM Research Group: Grant application to NIH/OCCAM.
Development of Natural Health Products for Cancer Patients: From Laboratory through Clinical Trials and Government Regulations.
Role: PI: reviews of antiangiogenic agents, immune modulators, and radiation sensitizeProject presented at Society for Integrative Oncology Conference, November 2007; San Francisco; and 14thAnnual Symposium on Complementary Health Care, December 2007; University of Exeter, UK . Reviews published since.
Publication of Current Oncology supplement titled Integrative Medicine: A Canadian and International perspective
CVT-E002, a proprietary extract of North American Ginseng, activates the vertebrate innate immune system to produce proinflammatory and anti-viral factors via MyD88 signaling. Rosenthal K, Newton J, Patrick A.
Status: Presented as abstract in FASEB, 2008. Full manuscript in preparation
A randomized trial of Codetron versus best supportive care to prevent radiation- induced xerostomia. Completed
A phase I/II study to examine the accuracy of spinal cord functional MRI scan in evaluating chemotherapy induced peripheral neuropathy and the efficacy of acupuncture and acupuncture-like transcutaneous nerve stimulator in treating this condition and blood flow in lumbar muscles.
Natural health products in the prevention and treatment of lung cancer: a systematic and scoping review of the literature.
Influence of therapeutic massage on the physiology of muscle and the central nervous system: evaluation by magnetic resonance spectroscopy and functional magnetic resonance imaging in healthy subjects and subjects with subacute low back pain.
RTOG Protocol 0537: A phase II/III study comparing acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) versus pilocarpine in treating early radiation-induced xerostomia
A pilot project to evaluate the effectiveness of a Japanese Herbal Medicine formula, Keishi-bukuryo-gan in alleviating hormonal ablation therapy induced vasomotor symptoms in prostate cancer patients.
Complementary Medicine '99: The Scientific Integration of Body, Mind and Spirit; University of Toronto and Ontario Medical Association; April 1999; Toronto
Exploring Bio-Psycho-Spiritual Approaches to Cancer Care; April 2000; McMaster University and Cancer Care Ontario; Hamilton
Complementary Medicine 2000: The Art and Science of Healing; University of Toronto and Ontario Medical Association; May 2000; Toronto
Complementary Medicine 2001: From Evidence to Integration; University of Toronto and Ontario Medical Association; June 2001; Toronto
Annual ASTRO Education session in Integrative Oncology; organizer and faculty; San Francisco; New Orleans; Salt Lake City; Atlanta; Denver; Philadelphia; 2001- 2006
Society for Integrative Oncology 2nd, 3rd, 4th annual conferences; co-chair; 2004- 2007
Integrating Wellness into Cancer Care: University of Toronto; Toronto; 2007.
Canadian Neuro-Oncology Conference; McMaster University; Niagara-On-The- Lake; May 1998
Complementary Medicine ‘98 Conference; University of Toronto and Ontario Medical Association; Toronto; April 1998
Comprehensive Cancer Care III; NCI, University of Texas and the Center for Mind- Body Medicine; June 2000; Washington D.C.
Comprehensive Cancer Care IV; University of Texas and the Center for Mind-Body Medicine; October 2001; Washington D.C.
Annual CancerGuides Courses; Center for Mind-Body Medicine and University of Minnesota; Snowmass; Berkley; Chicago; 2001-2005
Second Health and Spirituality Conference; University of Toronto; October 2002
Spirituality and Mental Health Conference, University of Ottawa, November 2002
ASCO Education Session and faculty; Integrative Oncology; June 2007
Society for integrative Oncology: Shanghai International Symposium: Integrative Oncology, Theory, Research and Practice; Fudan University Cancer Hospital, Shanghai, China; 2008
Acupuncture session and Botanicals for Symptom Support session at Society for Integrative Oncology Second Annual Meeting; November 2005; San Diego
From Bench to Bedside: Natural Health Products for Cancer Patients; Organizer and Chairperson of symposium at North American Research Conference on Complementary and Alternative Medicine; May 2006; Edmonton Alberta
Poster Review Session; Society of Integrative Oncology 3rd International Meeting; November 2006; Boston
Chair of Immunology panel; 4th International Society of Integrative Oncology Meeting; November 2007; San Francisco
Chair of Best Submitted Papers Session; 4th International Society of Integrative Oncology Meeting; November 2007; San Francisco
Chair of Methodology Symposium and Cancer & Complementary Therapies Sessions; 14th Annual Symposium on Complementary Health Care, 11th-13th December 2007, University of Exeter, UK
Chair of Herbal Panel for The Shanghai International Symposium: Integrative Oncology, Theory, Research and Practice at Fudan University Cancer Hospital, Shanghai, China, April 25-26, 2008
Faculty at CancerGuides Course; Berkley CA; January 2004
Palliative Care Grand Rounds, M.D. Anderson Hospital, March 2004
Complementary Therapies in Radiation Oncology: Practice Guidelines; Teaching faculty ASTRO; October 2004; Atlanta
Chinese Medicine: An Evidence Based Approach to Rehabilitation; Supportive Care: The Role of Nutrition: An Evidence-Based Approach; American Academy of Physical Medicine and Rehabilitation: October, 2004; Phoenix.
What is the Role of Integrative Oncology for Coping with Conventional Therapies and their Side-Effects? Swedish American Cancer Center Annual Oncology Professional Day; October 2004; Rockford, Illinois
Integrative Oncology in North America; and RCT of acupuncture-like TENS; Society for Integrative Oncology First International Conference; November 2004; New York
Integrative Oncology: A new specialty incorporating Complementary Care and Cancer Medicine; Scarborough CCAC Grand Rounds (Cancer and Palliative Care Services); January 2005, Toronto
Evidence-based acupuncture. The Michigan Integrative Oncology Symposium, St Mary's Healthcare and Lacks Cancer Center; September 2005;
Society of Clinical Research Associates (SoCRA) Annual Meeting; September 2005; Orlando, Florida.
The virtual laboratory: An opportunity to fast track Chinese herbal therapies into clinical practice through a novel research network. Canadian Institute of Chinese Medicinal Research; May 2006; Edmonton, Alberta
Integrative Oncology Research and Research Issues for bringing Natural Health Products into Clinical Practice; Society of Clinical Research Associates (SoCRA) September 2006; Chicago
Hamilton Health Sciences Pharmacy Oncology Network Regional Retreat; Natural Health Products in Oncology: The Good the Bad and the Ugly; September 2006
Complementary Medicine and Integrative Oncology; Lymphoma Foundation of Canada; November 2006; Hamilton, Ontario.
Organizer and speaker for ASTRO teaching session on Integrative Oncology; November 2006; Philadelphia
Society for Integrative Oncology 3rd annual conference; November, 2006; Boston
The future of CAM research: A panel discussion. 13th Annual Symposium on Complementary Health Care; December 2006, University of Exeter, UK .
Complementary Therapies for Maintenance of Health; Trends in Treating CLL: Educational Forum of Lymphoma Foundation of Canada; Niagara; April 2007.
Sutherland S; Sagar SM ; Aggrawal BB ; Boon H ; Carcache-Blanco E; Kelly K; Miller S; Newman RA. Tradition to Technology; Natural Health Products Research Society Annual Meeting; May 2007; Saskatoon, Canada
Integrative Oncology: Physical Therapies; Case studies; ASCO Education Session, July 2007; Chicago
Complementary Therapies for survivors; Ottawa Lymphoma Foundation; September 2007; Ottawa, Canada
Integrative Oncology to Improve Outcomes of Care. Integrating Wellness into Cancer Care Conference; University of Toronto; October 2007; Toronto
Integrative Oncology for Lymphoma Patients; North American Educational Forum on Lymphoma; Lymphoma Foundation of N. America; Marriot Brooklyn Bridge; October 2007; New York
The Role of Integrative Oncology in a Comprehensive Cancer Program; McGill University Medical Grand Rounds; November 2007; Montreal, Canada
Maintenance for Cancer Patients and Survivors; First Vineberg Family Public Lecture; November 2007: Montreal, Canada.
Phase II Study of Acupuncture-Like Transcutaneous Nerve Stimulation (ALTENS); 4th International Society of Integrative Oncology Meeting; November 2007; San Francisco
Biofield Healing Techniques: Pragmatic or Mechanistic: Does it Matter?; 4th International Society of Integrative Oncology Meeting; November 2007; San Francisco
Promoting Research Guidelines for Natural Health Products in Oncology; 14th Annual Symposium on Complementary Health Care, 11th-13th December 2007, University of Exeter, UK
A Phase II Study of ALTENS to Prevent Radiation-Induced Xerostomia in Head and Neck Cancer patients during radical Radiotherapy; 14th Annual Symposium on Complementary Health Care,11th-13th December 2007, University of Exeter, UK
Integrative Oncology for Cancer Patients: The Maintenance Program; Annie Appleseed Patient Support Group Meeting; January 2008; Palm Beach, Florida
Natural Health Products as Antiangiogenesis Agents; 3rd International Congress of Complementary Medicine Research; March 2008; Sydney, Australia
Authentication of Chinese Herbs for Oncology Research University of Sydney: Medical Foundation Building; April, 2008; Sydney, Australia
Standards of Botanical Research in Oncology; Integrative Oncology, Theory, Research and Practice; April 2008; Fudan University Cancer Hospital, Shanghai, China
Pain Control with Acupuncture and other Physical Interventions in an Integrative Oncology Program. 27th Annual Scientific Meeting of the American Pain Society; May 2008; Tampa, Florida
Natural Health Products in Oncology: The Good, the Bad, and the Ugly; 4th Annual Oncology Congress; September 2008; San Francisco
Integrative Care for Cancer Survivors Treated with Anti-Cancer Therapies; The Annual AICR Research Conference: Food, Nutrition, Physical Activity and Cancer; November 2008; Washington D.C.
Integrative Oncology- The Canadian Landscape. Cancer-CAM Research Workshop (University of Saskatchewan); November 6th 2008; Toronto.
Society for Integrative Oncology Presidential Speech; Atlanta; November 21, 2008.
Managing Xerostomia and other Side-Effects of Cancer Treatment with Complementary Therapies: The Evidence. Memorial Sloan Kettering cancer Center; New York, April 2009.
2009 North American Research Conference on Complementary and Integrative Medicine; Session: Integrative Medicine and Cancer Care: Research Methodology: How to evaluate outcome in the integrative oncology setting. Minneapolis, May 2009.
Creating an Integrative Practice. CancerGuides II Course. Washington DC, June 2009.
Spiritual Transformation and Integrative Health: What your Doctor may not Know. Chautauqua Institution, NY; July 2009.
Fifth Annual Chicago Supportive Oncology Conference: Acupuncture and Symptom Management. Elsevier Oncology; Chicago, October 2009.
A Western Science Perspective on Acupuncture Mechanisms; plus A Western Science Approach to Anti-Cancer Therapy with Herbal Medicine. In: Integrative Oncology
session of Symposium on Acupuncture and Meridian Studies 2009 (SAMS2009). October 2009; Seoul, Korea.
Cancer Center of CWRU and the Ireland Cancer Center of University Hospitals Case Medical Center, and the City Club Forum: With Gary Deng MD: Integrative Oncology: Role in a Comprehensive Cancer Center. October, 2009.
Sixth International Scientific Conference of the Society for Integrative Oncology, New York Academy of Medicine. Presidential Introduction and Panel Chair for Whole Systems in Cancer Care. New York, November, 2009.
Research Survey of Cancer Patient Preferences for Multimedia Communication Options. Sagar SM; Garchinski CM, McCarter H, Dawson J, Finn M, Paradis J.
4th Biennial Cancer Culture and Literacy Conference, Moffitt Cancer Center, May 2004.
Molecular Genetic Characterization of Serial Tumour Specimens from a Long-Term Survivor of Glioblastoma Multiforme. Saltman D, Kamel-Reid S, Wells J, Provias J, Sur M, Sagar S, McCarter H. Canadian Neuro-Oncology Conference; May 2004;
Research Survey of Cancer Patient Preferences for Multimedia Communication. Sagar SM; Garchinski CM, McCarter H, Dawson J, Finn M, Paradis J. Supportive Care in Cancer Conference (MASCC/ISOO 16th International Symposium), June 2004; Miami Beach.
Pilot Study of Acupuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy (CIPN); Wong RK, Sagar SM. NCI/OCCAM Meeting on Traditional Chinese Medicine Research; April 2006; Bethesda
Pilot Study of Acupuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy (CIPN). Wong RK, Sagar SM. University of Exeter Annual CAM Research Symposium; December 2006; Exeter UK.
Polysaccharide extracts from Chinese Medicinal Herbs. Sagar SM, Foley R, Wong RK, Rosenthal KL. Hamilton's Inaugural Health Research in the City; Jan 2007; McMaster University; Hamilton
Polysaccharide extracts from Chinese Medicinal Herbs. Sagar SM, Foley R, Wong RK, Rosenthal KL; Molecular Targets in Cancer Therapy, Fourth Biennial Meeting: Mechanism and Therapeutic Reversal of Immune Suppression in Cancer. H. Lee Moffitt Cancer Center & Research Institute; January 2007; Tampa, Florida
First Conference for Integrative Oncology Assesses Comforts, Clinical Benefits, and Challenges of Complementary and Alternative Medicine. Oncology Times; Feb 10, 2005: 14-15
Data Shows Benefits for use of Acupuncture in Alleviating Cancer Pain, Nausea and Xerostomia. Oncology Times; Feb 25, 2005: 17-18
Focus on Supportive Care: Acupuncture Shows Promise for Reducing CIPN Symptoms. Oncology News International; December 2005; 14(12):40
Cancer in the Mind's Eye; Globe and Mail. December 9, 2006: F5-F7.
Interview with Stephen M. Sagar. Focus on Alternative and Complementary Therapies (FACT) 2007; 12: 3-4.
FDA Warns Consumers, Companies Against Bogus Cancer Cures; Hematology Oncology Today; June 26, 2008: 9
The Eli and Edythe L. Broad Foundation: Modulating immune response of ulcerative colitis by acupuncture
Colorectal lymphoma simulating inflammatory colitis and diagnosed by immunohistochemistry. Sagar S, Selby P, Sloane J McElwain T. Postgrad Med J 1986; 62: 51-53.
Chronic primary abscess of the psoas muscle due to staphylococcus aureus. Sagar S, Webb J, Stoker. B J Hosp Med 1986; 35: 265-266.
Malignant multiple lymphomatous polyposis: Diagnosis and response to chemotherapy. Sagar S, Karp S, Falzon M. Clin Oncol 1990: 2: 230-234.
Olfactory sensations produced by high-energy photon irradiation of the olfactory receptor mucosa in humans. Sagar S, Thomas R, Loverock L, Spittle M. Int J Radiat Oncol Biol Phys 1991; 20: 771-776.
Metastasis to the penis from malignant melanoma: Case report and review of the literature. Sagar S, Retsas S. Clinical Oncology 1992; 4: 130-131.
Metastatic parathyroid carcinoma: A radiological, biochemical and symptomatic response to metastectomy. Thomas R, Bowling T, Cassoni A, Sagar S. J Royal Soc Med 1992; 85: 182.
Radical treatment of angiosarcoma of the scalp utilizing megavoltage electron beam therapy. Sagar S, Pujara C. B J Radiol, 1992; 65: 421-424.
A clinical audit of glottic cancer in Nova Scotia: A paradigm for effectiveness research. Sagar S, McKenna G, Nolan, M. Clin Oncol 1994; 6: 14-23.
Quantitation of nucleolar organizer regions by image analysis in glottic squamous cell carcinoma. Barnes P, Sagar S, Laybolt K, Roy P, Foyle A. Clin Invest Med 1999; 22: 36-43.
The treatment of persistent yawning with acupuncture. Wong R, Sagar S. Acupunct Med 2000; 18:124-126.
A phase I/II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head and neck cancer patients treated with radical radiotherapy. Wong R, Jones G, Sagar S, Fargas-Babjak A, Whelan T. Int J Radiat Oncol Biol Phys 2003; 57:472-480.
Lou L. Wright J, Gerstein H, Hodson DI, Poon I, Sagar S , Sathya J. Thyroid function screening following radiation therapy for cancers of the head and neck: a survey of Canadian practice patterns. Current Oncology 2004; 11: 68-71.
Acupuncture treatment for chemotherapy-induced peripheral neuropathy- a case series. Wong R, Sagar S. Acupunct Med 2006; 24: 87-91.
Research on Therapeutic Massage for Cancer Patients: Potential Biological Mechanisms. Sagar S, Dryden T, Myers C. J Soc Integrat Oncol 2007. 5: 155-62.
The current role of antiemetic drugs in oncology: A recent revolution in patient symptom control. Sagar S. Cancer Treat Revs, 1991; 18: 95-135.
Tumour blood flow: Measurement and manipulation for therapeutic gain. Sagar S, Klassen G, Barclay K, & Aldrich J. Cancer Treat Revs; 1993; 19: 299-349.
Nitric oxide and anti-cancer therapy. Sagar S, Singh G, Hodson D, Whitton A. Cancer Treat Revs 1995; 21: 159-181.
Integration of Chinese medicine into supportive cancer care: A Modern Role for an Ancient Tradition. Wong R, Sagar C, Sagar S. Cancer Treat Revs 2001; 27:235-246.
Chinese medicine and supportive cancer care: A model for an evidence-based, integrative approach. Sagar S, Wong R. Evidence-Based Integrative Medicine 2003. 1: 11-25.
Should patients take or avoid antioxidant supplements during anticancer therapy? An evidence-based review. Sagar S. Current Oncology 2005;12(2):44-54.
Integrative oncology for comprehensive cancer centres: definitions, scope and policy. Sagar S, Cassileth B. Current Oncology 2005; 12: 103-117.
Targeting angiogenesis with integrative cancer therapies. Yance D, Sagar S. Integrat Cancer Ther 2006; 5: 9-29.
Natural health products that inhibit angiogenesis: A potential source for investigational new agents to treat cancer (part one). Sagar S, Yance D, Wong R. Current Oncology 2006; 13:14-26.
Natural health products that inhibit angiogenesis: A potential source for investigational new agents to treat cancer (part two). Sagar S, Yance D, Wong R. Current Oncology 2006; 13: 99-107.
Massage therapy for cancer patients. Sagar S, Dryden T, Wong R. Current Oncology 2007; 14: 45-56.
Future directions for research on Silybum marianum for cancer patients. Sagar S. Integrat Cancer Ther 2007; 6: 166-73.
Integrative Oncology Practice Guidelines. Deng G, Cassileth B, L Cohen L, Johnstone P, Kumar N, Vickers V, Abram D, Rosenthal D, Sagar S, Tripathy D. J Soc Integr Oncol 2007; 5: 65-84.
Chinese Medicine and Biomodulation in Cancer Patients (part one). Sagar S, Wong R. Current Oncology 2008; 15(1):42-48.
Chinese Medicine and Biomodulation in Cancer Patients (part two). Sagar S, Wong R Current Oncology 2008; 15(2): 78-79 (web: 8-30).
Clinical audit of an integrative oncology program: How should we measure outcome? Sagar S. FACT 2008; 13: 168-172.
Should supplemental dietary antioxidant administration be avoided during chemotherapy and radiation therapy? Lawenda B, Kelly K, Ladas E, Sagar S, Vickers , Blumberg J. JNCI 2008; 100:773-83.
How do we evaluate outcome in an integrative oncology program? Sagar S. Current Oncology 2008; 15 (suppl 2): S78-S82 (web: S8-S12).
Research and regulatory issues for integrative oncology. Sagar S, Wong R. Current Oncology. 2008; 15 (suppl 2): S107-S108 (web: S53-S63).
Acupuncture as an evidence-based option for symptom control in cancer patients. Sagar S. Current Treatment Options in Oncology. 2008, Aug 8. [Epub ahead of print].
Sagar S and Lawenda B. The Role of Integrative Oncology in a Tertiary Prevention Survivorship Program. Preventive Medicine 2009; 93-98.
Gary E. Deng, Moshe Frenkel, Lorenzo Cohen, Barrie R. Cassileth, Donald I. Abrams, Jillian L. Capodic, Kerry S. Courneya, Trish Dryden, Suzanne Hanser, Nagi Kumar, Dan Labriola, Diane W. Wardel, Stephen Sagar. Evidence-Based Clinical Practice Guidelines for Integrative
Oncology: Complementary Therapies and Botanicals. J Soc Integrat Onc 2009; 7: 85–120.
Restored Harmony: An evidence based approach for integrating Traditional Chinese Medicine into Complementary Cancer Care. Sagar S; 2001; DDC; Hamilton, Ontario.
The neurobiology of consciousness and spiritual transformation in healing. Sagar S; Chapter 17: 285-306; in Spirituality and Health: Multidisciplinary explorations. Meier A, O'Connor T, VanKatwyk P, eds. 2005; Wilfred Laurier University Press, Waterloo.
The scientific basis of Chinese medicine and cancer care: A Western medicine perspective. Sagar S, Wong R; Chapter 1: 1-54; in Alternative Treatment of Cancer (Annals of Traditional Chinese Medicine Volume 3); Leung P-C, Fong H, eds. 2007; World Scientific Press, Singapore.
Acupuncture as an evidence-based option for symptom control in cancer patients. Sagar S. Current Treatment Options in Oncology. 2008, Aug 8. [Epub ahead of print]Print: 2008; 9; 117-126.
Alternative therapies as primary treatments for cancer. Stephen M. Sagar; in Integrative Oncology; Chapter 26: 502-529. Abrams D & Weil A; 2009; Oxford University Press, New York.
Development of anti-angiogenesis therapies for treating cancer from Chinese medicinal herbs. Sagar S, Wong, R, Yance D; in Bioactive Natural Products; Gupta V, ed. 2009; Studium Press LLC; Houston.
Sagar S, Sze D, Wong R; in Bioactive Natural Products; Gupta V, ed. 2009; Studium Press LLC; Houston.
Chapter 13: Integrative Medicine and Cancer Control. Leis A, Verhoef M, Sagar S, Oneschuk D, Balneaves L, Seeley D; in: Oxford Textbook of Cancer Control. Sutcliffe S, ed. 2009. Oxford University Press; New York; 2010.
Chapter 6: Controlling Radiation-induced Injuries with Chinese Medicine. S. Sagar and R. Wong; in: Supportive Cancer Care with Chinese Medicine; Cho, William (Ed) 2010; Springer, Hong Kong.
Chapter 1: Supportive Cancer Care using Chinese Medicine; R. Wong and S. Sagar; in: Supportive Cancer Care with Chinese Medicine; Cho, William (Ed) 2010; Springer, Hong Kong.
Non-Peer-Reviewed Manuscripts (Editorials, Invited Commentaries, Abstracts and Letters):
Homeopathy: Does a teaspoon of honey help the medicine go down? Sagar S. Current Oncology 2007; 14: 126-7.
Integrative oncology and an integrative cancer journal. Sagar S. Current Oncology 2008; 15(4): (web:1-2).
Integrative Oncology: A Canadian and international perspective. Sagar S, Leis A. Current Oncology 2008; 15 (suppl 2): S71-S73 (web: S1-S3 ).
The scientific basis of Chinese medicine and cancer Care: A Western medicine perspective. Sagar S, Wong R . Asia-Pacific Biotech News 2007; 11; 17/18: 1168-1185.
Reviews:
Research Issues in Integrative Oncology. Sagar S, Wong R. SoCRA Source November 2007; 54: 14-24.
Massage therapy for cancer patients. Sagar S. Massage Australia. 2008; 59:
14-23.
Report on the Ninth International Congress of Radiation Research: Toronto, Canada, July, 1991. Sagar S. Cancer Topics, 1991; 8: 107-108.
Progress in cancer treatment symptom control: alleviation of emesis by the 5-HT3 antagonists. Sagar S. Nova Scotia Med J 1993, Feb: 253-254.
Current role of antiemetic drugs in oncology. Sagar S. Capsules and Comments in Oncology Nursing 1993; 1: 26-27.
Integrative Tumor Board: Breast Cancer: The Role of Radiation Oncology and Complementary Care. Sagar S. Integrat Cancer Ther 2002; 1: 184-185.
Integrative Tumor Board: Recently Diagnosed Lung Cancer: Mind-Body Medicine Analysis. Sagar S, Gordon J. Integrat Cancer Ther 2002; 1: 259-261.
Debate (with Michael Baum): There is no relevant benefit for cancer patients to use CAM. Sagar S. FACT; 2002; 7: 242-243.
Dissociation between radiotherapy patients' experience of anxiety and their sense of well-being after hypnotherapy. Sagar S. FACT 2005; 10: 217-18.
Chemotherapy plus high-dose antioxidants for non-small cell lung cancer: No significant influence on outcome. Sagar S. FACT 2005; 10: 294-6.
State of the art and science of integrative oncology in North America. Sagar S. J Soc Integrat Oncol 2005; 3: 127-9.
Yoga can contribute to the psychosocial rehabilitation of some cancer survivors. Sagar S. FACT 2006; 11: 137-8.
Is there a role for acupuncture for the treatment of hot flashes in breast cancer patients? Sagar S. FACT 2008; 13: 112-13.
What size chest tube for pleural effusions? Thomas R, Sagar S; B J Hosp Med; 1990; 43:184.
Ondansetron: Further progress in the prevention of nausea and vomiting induced by anticancer chemotherapy. Sagar S, Bayliss M, Chong S-L, Retsas S. Clinical Oncology; 1991; 3:183.
Treating elderly patients with breast cancer. Sagar S, Lopez P. BMJ; 1992; 304: 1376-1377.
Staging of breast cancer. Lopez P, Sagar S Lancet, 1992; 339: 1360.
Evidence based medicine: No guidance is provided for situations for which evidence is lacking. Jones G, Sagar S; BMJ: 1995; 311: 258.
The changing role of hospital consultants. Sagar S, Jones, G, Rhydderch H, Thorson B. BMJ, 1995; 311: 332.
Rationing Health Care. Jones G, Sagar S; The World and I; 1996; January: 18-19.
Health Care-Business Partnership is Problematic. Jones G, Sagar, S; The Medical Post, 1996; June 4: 13.
Unproven Cancer Therapies. Sagar S; Annals of the Royal College of Physicians and Surgeons of Canada, 1998; 160: 31.
Statistics can kill hope for cancer patients; Sagar S; Medical Post, November 17, 1998: 16
Reader’s anti-alternative medicine rant lacks evidence. Sagar S; The Medical Post, July 10, 1999.
Alternative Views on Alternative Therapies. Sagar S; CMAJ; 1999; 160:1697-98.
Cancer care workers in Ontario: prevalence of burnout, job stress and job satisfaction: an explanation based on “spiritual poverty”. Jones G, Sagar S, Wong R. CMAJ; 2000; 163: 80.
Homeopathy, fundamentalism, and the memory of water: Reply to Lionel Milgrom. Sagar S; Current Oncology 2007; 14: 222-3.
Response: Re: Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
Brian D. Lawenda; Jeffrey B. Blumberg; Stephen M. Sagar
JNCI Journal of the National Cancer Institute 2008; doi: 10.1093/jnci/djn348
Medical Writings: Book Notes: The ACP Evidence-Based Guide to Complementary and Alternative Medicine, Jacobs BP, Gundling K, eds. Stephen Sagar. Annals of Internal Medicine 2009; 151: 368.
Patient Educational Material (2008):
Complementary Therapies in Oncology Booklet for the Canadian Cancer Society. Joint author as part of Cancer-CAM Research Team (supported by the Centre for Behavioural Research and Program Evaluation through the National Cancer Institute of Canada)
Chapter: Opportunities to fast-track Chinese herbal therapies into clinical practice through research networks. Sagar S; World Sciences and Technologies: TCM Modernization (WST- TCMM) 2009.
Lawenda B, Bardwell W, Mills PJ, Sanford A, Friedenthal MS, Sagar SM. The relationship between psychosocial stress and cancer: the role of a biology systems based model and the promise of integrative oncology. Submitted
Wong RK, Sagar SM, Chen BJ, Yi GY, Cook R.
A Phase II Randomized Controlled Trial of Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) for the Prevention of Radiation-Induced Xerostomia in Patients Treated for Head and Neck Cancers; JSIO; accepted; 2009.
|
About the Foundation 
